Market closedNon-fractional
Delcath Systems/DCTH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Delcath Systems
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
Ticker
DCTH
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
New York, United States
Employees
76
Website
www.delcath.com
Delcath Systems Metrics
BasicAdvanced
$221M
Market cap
-
P/E ratio
-$2.55
EPS
0.55
Beta
-
Dividend rate
Price and volume
Market cap
$221M
Beta
0.55
Financial strength
Current ratio
2.522
Quick ratio
2.15
Long term debt to equity
6.949
Total debt to equity
57.969
Interest coverage (TTM)
-42.25%
Management effectiveness
Return on assets (TTM)
-75.22%
Return on equity (TTM)
-400.68%
Valuation
Price to revenue (TTM)
33.772
Price to book
13.74
Price to tangible book (TTM)
13.74
Price to free cash flow (TTM)
-4.246
Growth
Revenue change (TTM)
56.81%
Earnings per share change (TTM)
-32.16%
3-year revenue growth
38.34%
3-year earnings per share growth
-20.80%
What the Analysts think about Delcath Systems
Analyst Ratings
Majority rating from 6 analysts.
Delcath Systems Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$3.1M
520.00%
Net income
-$11M
-0.00%
Profit margin
-358.06%
-83.87%
Delcath Systems Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-
-
-
-
-
Expected
$0.00
$0.00
$0.00
$0.00
-$0.36
Surprise
-
-
-
-
-
Delcath Systems News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Delcath Systems stock?
Delcath Systems (DCTH) has a market cap of $221M as of July 06, 2024.
What is the P/E ratio for Delcath Systems stock?
The price to earnings (P/E) ratio for Delcath Systems (DCTH) stock is 0 as of July 06, 2024.
Does Delcath Systems stock pay dividends?
No, Delcath Systems (DCTH) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next Delcath Systems dividend payment date?
Delcath Systems (DCTH) stock does not pay dividends to its shareholders.
What is the beta indicator for Delcath Systems?
Delcath Systems (DCTH) has a beta rating of 0.55. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Delcath Systems stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.